The Neural Code of Cancer: 2026 Strategic Brief

The Neural Code of Cancer: 2026 Strategic Brief

From “Immune-Hot” to “Neuro-Active”: The Next Capital Rotation in Oncology.

For the last decade, the market has been obsessed with Immuno-Oncology. But the data shows the tide is turning. A new, high-value cluster has emerged in the NIH funding ecosystem: Cancer Neuroscience.

This is not just biology; it is a market signal.

I have analyzed over 3,000 active NIH grants using the proprietary Grant Compass™ methodology to map the “Neural Code”—the specific mechanism where tumors hijack the peripheral nervous system to drive metastasis and cognitive decline (“Chemobrain”).
Buy Now